ArticleJournal of cellular and molecular medicine2025

Assessing Auranofin for Second-Line Use in Chemoresistant Ovarian Cancer: Effects on Tumour Spheroid and Primary Cell Growth.

Rosamaria Militello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.